NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/31/2024
Back to search
Official data from USPTO
MRNADVANCE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
MRNADVANCE
ST13
US500000098211073Class
5, 9, 42
Filing
98211073
Registration
7630312
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
26
Latest update
12/31/2024
Trademark type
Word
Nice classes
5, 9, 42
Filing date
10/05/2023
Registration date
12/31/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/31/2024
Last transaction
12/31/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
99
Owner location
Yeonsu-gu, Incheon, KR
Examiner
BLAZICH, JOAN MICHELE
Law office
N40
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Samsung Biologics Co., Ltd.
Representatives
Lisa C. Pavento MEUNIER CARLIN & CURFMAN LLC
Technical classification
Nice Classes
Class 5Class 9Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Reagents for medical use for measurement of HBs antibody; medicines consisting of RNA for treating cancer; crude medicines for treating ocular diseases; cellular function activating agents for medical purposes; colostral antibodies for veterinary purposes; chemico-pharmaceutical preparations for treating cancer; chemical preparations for use in DNA analysis for medical purposes; chemical preparations for use in RNA analysis for medical purposes; bacterial preparations for medical and veterinary use; chemical preparations for treating cancer for medical or veterinary purposes; biotechnological preparations for medical purposesreagents for medical purposes; biological reagents for medical purposes; biochemical preparations for medical purposes; reagents for medical use; bispecific colostral antibody for medical use; trace element preparations being dietary supplements for human use; clinical medical reagents; pharmaceutical preparations for the treatment of cancer; medical diagnostic reagents for the detection of mRNA antigens; colostral antibodies for medical purposes
Class 9
DNA analysis apparatusmedical laboratory research instruments for DNA analysis; DNA chips; RNA microarrays; cartridges for storing specimen used for RNA analysis apparatussolid phase extraction cartridges for laboratory use; reagent cartridges used for RNA analysis apparatussolid phase extraction cartridges for laboratory use; reagent containers used for RNA analysis apparatussolid phase extraction cartridges for laboratory use; RNA analysis apparatusmedical laboratory research instruments for RNA analysis; RNA sequencing deviceslaboratory devices for detecting genetic sequences; RNA chips; genome analyzer machineslaboratory devices for detecting genetic sequences and related downloadable computer operating software; devices for analyzing genome informationlaboratory devices for detecting genetic sequences; bioreactors for cell culturing for scientific research; biochip analyzing apparatus for research or scientific purposes; biochip sensors for sensing antigens; biochips for research or scientific purposes; liquid dosage devices that measure the amounts to be dispenseddispensers for measuring and dispensing of distilled waternot for medical use; incubators for cell culturenot for medical purposes; cellchip inspectors being optical inspection apparatus; devices for analyzing protein sequence used as laboratory apparatuslaboratory devices for detecting genetic sequences; physical and chemical machines for laboratory use; physical and chemical apparatus for analyzing geneslaboratory devices for detecting genetic sequences; gene amplifiers being DNA microarrays; mRNA microarrays; RNAMRNADNA microarrays; nucleic acid sequencing devices and nucleic acid synthetic apparatuslaboratory devices for detecting genetic sequences; diagnostic chips for inspecting blood plasma laboratory apparatusDNA chips; diagnostic chips for analyzing blood plasma laboratory apparatusDNA chips
Class 42
RNA technology research and development; providing temporary use of non-downloadable web application for sharing information in the RNA technology field; research in the field of RNA repair technology; research and development of RNA chips; research relating to sciencescientific research in the field of RNA; RNA screening for scientific research purposes; RNA sequence analysis for scientific research purposes; multiple nucleic acid analysis for scientific research purposes; molecular analysis for scientific research purposes; development of new technology for others in the field of biotechnology; biochemical analysis; drug discovery services; design of new products for others; pharmaceutical research and development; clinical studies of medicinesconducting clinical trials for others; services for assessing the efficiency of pharmaceuticalsproduct quality testing services; fusion protein analysis for scientific research purposes; computer programming services in the medical field; medical laboratories; management assistance services for medical image dataengineering services; medicine research being medical research; analysis and evaluation of medical product developmentproduct quality testing services; providing scientific information on the testinginspection and research of medical products; scientific and medical laboratory services relating to the production of bispecific antibody antibodies; pharmaceutical drug development for bispecific antibody; bispecific antibody research and development; evaluating of clinical trial progressconducting clinical trials for others; clinical trialsconducting clinical trials for others; providing temporary use of onlinenon-downloadable computer operating software for genome analyzer machines
Publications
History of USPTO decisions and trademark events.
26 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
12/31/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/12/2024
PUBO
PUBLISHED FOR OPPOSITION
11/12/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/23/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/01/2024
XAEC
EXAMINER'S AMENDMENT ENTERED
09/24/2024
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09/24/2024
GNEA
EXAMINERS AMENDMENT E-MAILED
09/24/2024
CNEA
EXAMINERS AMENDMENT -WRITTEN
09/24/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/13/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/13/2024
ALIE
ASSIGNED TO LIE
09/13/2024
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
04/26/2024
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
02/08/2024
GNSL
LETTER OF SUSPENSION E-MAILED
02/08/2024
CNSL
SUSPENSION LETTER WRITTEN
02/08/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/01/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/31/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/31/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/07/2023
GNRT
NON-FINAL ACTION E-MAILED
11/07/2023
CNRT
NON-FINAL ACTION WRITTEN
11/07/2023
DOCK
ASSIGNED TO EXAMINER
10/30/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
10/14/2023
NWAP
NEW APPLICATION ENTERED
10/09/2023
Continuous trademark protection
Get notified about every new filing that threatens MRNADVANCE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.